The 23rd Pharmaceutical & Medical Device Ethics and Compliance Congress Features Behavioral Compliance: Overview and Application for Pharma and Medical Device Ethics and Compliance Leaders
  • A Hybrid Onsite Conference and Internet Event
  • Sponsored by Pharmaceutical Compliance Forum
  • Media Partners: Policy & Medicine Compliance Update
  • October 24-26, 2022
  • Capitol Hyatt, Washington, DC

Phone: 800-503-7419


Sally Molloy, JD
Deputy Chief, Fraud Section, US Department of Justice, Washington, DC
Behavioral compliance is the design and management of compliance programs that draw from behavioral predictions about individual and organizational behavior. In this two-part workshop, behavioral compliance expert Prof. Todd Haugh breaks down how the tools of behavioral science can be harnessed in ethics and compliance. In Part I, participants will learn research-based behavioral theory and how to apply it in their organizations. In Part II, participants will hear from a panel of senior compliance leaders whose companies are at differing stages of their behavioral compliance journey. Panelists will share how behavioral science is currently being used in their companies, best practices, and pitfalls. Participants will leave inspired to use behavioral compliance tools to improve their own E&C programs and with actionable steps to make it a reality.

Steven Cohen, MBA
Associate Vice President & Chief Ethics and Compliance Officer, North America and Canada, Eli Lilly

Cari A. Gallman, JD
Senior Vice President, Chief Compliance and Ethics Officer, Bristol Myers Squibb

Kirsten Mayer, JD
Former Head of US Compliance, Vice President Legal, Argenx

Todd Haugh, JD
Associate Professor of Business Law and Ethics, Kelley School of Business, Indiana University (Moderator)

WASHINGTON, DC USA -- PHARMA UPDATE NEWS SERVICE™ -- OCTOBER 12, 2022: The Pharmaceutical Compliance Forum (PCF) executive committee is pleased to announce that the Twenty-Third Pharmaceutical & Medical Device Ethics and Compliance Congress is returning to the Hyatt Regency on Capitol Hill in Washington, DC on October 24-26, 2022.


Charlene Keller Fullmer, JD
Assistant United States Attorney; Deputy Chief, Affirmative Litigation; US Attorney's Office for the Eastern District of Pennsylvania, Philadelphia, PA

Catherine (Katie) Gray, PharmD
Acting Director, Office of Prescription Drug Promotion, US Food and Drug Administration, Baltimore, MD

Mary A. Inman, JD
Whistleblower Counsel; Partner, Constantine, San Francisco, CA and London, UK

Kelly Begg Lawrence, JD
Assistant US Attorney & Chief, Health Care Fraud, District of Massachusetts, US Department of Justice, Boston, MA

Glenn Leon, JD
Fraud Section Chief, Criminal Division, US Department of Justice; Former SVP & Chief Ethics & Compliance Officer, Hewlett Packard Enterprise (HPE), Washington, DC

Sally Molloy, JD
Deputy Chief, Fraud Section, US Department of Justice, Washington, DC

Mary E. Riordan, JD
Senior Counsel, Office of Counsel to the Inspector General, Office of the Inspector General, US Department of Health and Human Services, Washington, DC

Julie Ritchie Wagner, JD
Senior Assistant General Counsel, PhRMA; Former Senior Counsel, HHS Office of Counsel to the Inspector General, Washington, DC

Jamie Yavelberg, JD
Director, Fraud Section, Civil Division, US Department of Justice, Washington, DC

  • We are thrilled to welcome you back to Washington DC for the in-person/hybrid PCF Congress!
  • Join us live to take advantage of numerous interpersonal networking opportunities with colleagues and educational opportunities at our robust exhibit hall with our industry partners
  • An invitation-only, closed-door Chief Compliance Officer (CCO) Roundtable on the morning of Tuesday, October 25 For more information contact
  • Annual reports and updates provided by DOJ, FDA, and OIG
  • Over 30 current topics addressing crucial ethics, compliance and legal issues
  • An industry-only, closed-door session for pharma and device ethics, compliance and legal professionals on Wednesday, October 26


Khelin N. Aiken, JD
Partner, North America FDA Practice, Baker McKenzie; Former Regulatory Counsel, FDA

Punkaj T. Amin, MBA, CFE
Compliance Officer, Global Wound Management, Smith & Nephew

Madelyn Archibald
Compliance Specialist, Bioventus

Meredith S. Auten, JD
Partner, Morgan, Lewis & Bockius LLP

Kristiana Bankova, MS
Senior Manager, Forensics & Integrity Services, EY

Eric M. Baim, MA, JD
Partner, Dovetail Consulting Group LLC; Former VP Compliance US, Shire

Rachel Batykefer
Senior Director, Integrity & Compliance CIA Operations, Mallinckrodt

Ann E. Beasley, JD
Vice President and Chief Compliance Officer, Zai Lab

Allison Benkert, MBA
Director Global Compliance Investigations, Seagen

Haskell Berman
Senior Vice President, State Affairs at HealthCare Institute of NJ

Joshua Blank, JD
Senior Attorney, Arnold & Porter

Eric Bolesh
Chief Operating Officer, Cutting Edge Information

Ryan Bonistalli, JD
Senior Director, Compliance, Ultragenyx Pharmaceutical

Keysha Bradford
Director of Compliance, Amplity Health

Adam L. Braverman, JD
Partner, Morrison & Foerster, Former US Attorney, Southern District of California

Eve M. Brunts, LLM, JD
Partner, Ropes & Gray

Terra Buckley, JD
Vice President, Head of Compliance Advisory Services, MedPro Systems; Vice President Compliance, Mesoblast

Tim Canonico
Principal, Pharmaceutical & Life Sciences, Risk & Regulatory Leader, PwC

Susy Cardoso, JD, LLM
Former Executive Director of Ethics & Compliance, Amarin

Craig Carpenito, JD
Partner, King & Spalding; Former US Attorney, New Jersey

Cynthia Cetani, LPEC
Chief Integrity & Compliance Officer, Indivior

Cheryl Chamallas
Sr. Director, Global Compliance Risk, argenx

Masha Chestukhin, MSJ
Associate Director, Compliance Officer R&D, IA, FMV, Sanofi Genzyme

Shoshanna Clark, JD
Head of USBU Ethics & Compliance Operations, Takeda

Steven Cohen, MBA
Associate Vice President & Chief Ethics and Compliance Officer, North America and Canada, Eli Lilly

Chris Corallo
Compliance Officer, North America, Convatec

Zachary Coseglia, JD
Managing Principal & Head of Innovation, R&G Insights Lab, Ropes & Gray

Clarissa Crain
Managing Director, Deloitte & Touche LLP

David W. Cromley, JD
Associate Vice President, Global Compliance Organization, Merck

Tiffany Cummings-Damiani, MBA
Vice President and Head of Global Compliance, Insmed Incorporated

Donna Daniels, JD
Managing Director, Forensic & Integrity Services, EY

Mahnu V. Davar, MA, JD
Partner, Arnold & Porter

BJ D'Avella, MBA
Life Sciences Consulting Group Leader, Paul Hastings

James M. Dawson
Vice President, Compliance Solutions, Qordata

Jake DeBoever, JD
Vice President, Chief Compliance Officer, Dermavant Sciences

Chris DePhillips, JD
Senior Vice President, Chief Operating Officer and General Counsel, Porzio Life Sciences

Stefanie A. Doebler, JD
Partner and Co-chair, Health Care Practice Group, Covington & Burling LLP

Avia M. Dunn, JD
Partner, Skadden, Arps, Slate, Meagher & Flom LLP

Gildas Durand
Principal, Forensic & Integrity Services, EY

David Falcone
Associate Vice President Global Compliance, Merz Aesthetics

J. Mark Farrar, CPA, CFE, CFF, MSJ, CIPP/US
Managing Director, Epsilon Life Sciences LLC

Nicole L. Felician, JD
Executive Director, Legal Regulatory, Digital Health, Patient Centricity, Cell Therapies, Astellas Pharma US

Margaret K. Feltz, MA, JD
Vice President, Ethics and Compliance, Chief Compliance Officer, Purdue Pharma LP

Kellie Fidler, MBA, PMP
Senior Director, Compliance Risk Assessment, Monitoring and Operations, Bristol-Myers Squibb

Melissa Fitzgerald, JD
Privacy Officer, Olympus Corporation of the Americas

Bethany Fox, JD
Vice President, Commercial Legal Affairs, Exelixis

Sara Frank, JD
Principal, Choate, Hall & Stewart LLP

Sarah A. Franklin, JD
Partner and Vice-chair, Life Sciences Litigation and Investigations Practice Group, Covington & Burling LLP

Cari A. Gallman, JD
Senior Vice President, Chief Compliance and Ethics Officer, Bristol Myers Squibb

Nereyda Garcia, JD
Head, Ethics & Compliance, US Business Unit, Takeda

Gary F. Giampetruzzi, JD
Partner, Paul Hastings

Tara K. Giunta, JD
Partner, Paul Hastings

Edward P. Glynn, MBA
Principal, EY

Gejaa T. Gobena, JD
Partner, Hogan Lovells; Former Deputy Chief, Fraud Section, Criminal Division, USDOJ

Tom Gregory, MBA, CPA
Partner, Forensic & Integrity Services, EY

Noor Haq, MBA, MS, CCEP
Executive Director, US Compliance, Amgen

Beth Hardcastle, JD
Partner, Sidley Austin LLP

Judith Haron, JD
Assistant General Counsel, PhRMA; Former Acting Chief Counsel, HHS

Todd Haugh, JD
Associate Professor of Business Law and Ethics, Kelley School of Business, Indiana University

Saul B. Helman MD, MBA
President, Epsilon Life Sciences

Kevin Henley, JD
Vice President, US Chief Compliance Officer, Otsuka America Pharmaceutical, Inc

Michael Hercz, JD
Senior Vice President & General Counsel, Sentynl

Emily F. Hodge, JD
Partner, Choate, Hall & Stewart LLP

Denis Jacob
Managing Director, Risk & Regulatory, PwC

Brenna E. Jenny, JD
Partner, Sidley

Abe Kassis, MBA, PhD
Senior Director, Global Head of Compliance and Legal Operations, Bausch + Lomb

Jeffrey Kawalek, MBA
Deputy, Chief Compliance Officer, Jazz Pharmaceuticals

Andrea Kocharyan, JD
Vice President, Head of Legal and Compliance, Zealand Pharma

Daniel Koerner
Senior Director, Potomac River Partners

Kirt Kraeuter, MGA
Senior Director, Corporate Compliance, Moderna

JJ Kuhn, JD
Vice President, Chief Counsel, Global Investigations, Medtronic

Stephanie Kurteff, JD, HCCP
Head of Compliance, Healthcare Compliance Officer, Medicines360

Rebekah Latchis, JD
Senior Director, Americas Office of Ethics and Compliance, Medtronic

Rachel Lei, JD
Vice President and General Counsel, Aldevron

Kirsten Liston
Principal and Founder, Rethink Compliance

Michael K. Loucks, JD
Partner, Skadden Arps LLP; Former Acting US Attorney, Massachusetts, DOJ

Seth H. Lundy, JD
Partner, FDA and Life Sciences, King & Spalding

Kevin J. Ma, JD
US Head of Compliance & Managing Counsel, PharmaEssentia USA

Jason Macias, JD
Head of Risk Assessment, Monitoring, Transparency, Global Trade, and Medical Affairs Compliance, Viatris

Jim Massey, MS
Chief Sustainability Officer, Zai Lab

Chris C. Matteson
Senior Manager, Forensic & Integrity Services, EY

Kirsten Mayer, JD
Former Head of US Compliance, Vice President Legal, Argenx

Dana S. McMahon, JD
Vice President, Global Chief Compliance Officer, Stryker

Rore Middleton, JD
Vice President, Compliance and Ethics at Blueprint Medicines, Member of Chief

David Mortlock, JD
Managing Partner, Global Trade & Investment Group, Willkie Farr & Gallagher LLP

Gregory S. Moss, JD
Chief Corporate Strategy and Legal Officer, Evommune

Lucy Muzzy, JD
Vice President, Compliance - M&A/Business Development, Government Agreements, Digital Health & Artificial Intelligence, Pfizer

Gregory F. Noonan, JD
Partner, Hogan Lovells; Former AUSA, Massachusetts & Southern District of California

Katherine Norris, MPA
Managing Director, Epsilon Life Sciences

Kristen Oberg, JD
Senior Vice President, Legal & Compliance, Mycovia Pharmaceuticals

Daniel O'Connor
Senior Vice President, PharmaCertify

Jackie Parris
Director, Compliance, Incyte Corporation

Chelsea Ott, JD
Director, Global Regulatory, MedPro Systems

Mohammad Ovais
Chief Executive Officer, Qordata & Veraqor

Amy Pawloski, CCEP
President, Strategic Versatility

Veleka R. Peeples-Dyer, JD
Chief Legal Officer and Chief Compliance Officer, Opentrons Labworks

Danielle Pelot, JD
Partner, Choate, Hall & Stewart LLP

Joseph Philipose, JD
Senior Vice President, Chief Compliance Officer, Emergent Biosolutions

Zoe Philippides, JD
Senior Vice President, Chief Ethics, Compliance & Privacy Officer, Moderna

Susan Pietras
Global Project Lead - Training, Communication and Policies, Sanofi

Lawrence P. Platkin, JD
Vice President and Head, U.S. Office of Compliance, Bayer US

Cory Potomis, MS
Director, Ethics & Compliance Strategy & Operations, Novo Nordisk, Plainsboro, NJ

Nikki Reeves, JD
Partner & Co-chair, Life Sciences and Healthcare Industry Group, King & Spalding

Jennifer A. Romanski, JD
Senior Vice President, Porzio Life Sciences, LLC; Principal, Porzio, Bromberg & Newman PC

Howard Root, JD
Chairman, Reprise Biomedical; Former, CEO & Co-Founder, Vascular Solutions

Jeff Rosenbaum, MBA
Partner & Co-Founder, Dovetail Consulting Group

David Ryan, JD
Vice President and Chief Compliance Officer, Epizyme

Nashmil Sadjadi
Associate Director Compliance Operations, Exelixis

Monica Schroeter, CPA, CISA
Senior Director, Compliance & Privacy , SK Life Science

Michael L. Shaw, JD
Principal, Global Head of Risk & Compliance, ZS

Tara Shewchuk, JD, LLM
Global Chief Ethics and Compliance Officer, Medtronic

Paul Silver
Principal, Regulatory & Compliance Life Sciences Leader, Deloitte Advisory

Ed Sleeper, MS
Ethics & Compliance Officer (U.S. & Europe), HUTCHMED

Tim Slone, MS, HCCP
Vice President, Global Compliance, Novavax

Damon Strickland
Associate Vice President, Ethics & Compliance Global Operational Capabilities, Eli Lilly

Kaarthick Subramanian, MBA
Chief Compliance Officer, Atlas Systems

Jack Tanselle, MBA
Managing Director, Deloitte & Touche LLP

Bryan Timer, MBA
Director, Global Compliance, Data Analytics and Transparency COE, Merck

Kelly J. Tope, JD, MBA
Head of USBU Monitoring and Reporting Operations, Takeda

Annalisa Torrente
Director, Medical Governance & Operations, POINT Biopharma

Manny Tzavlakis
Managing Partner, Helio Health Group; Chief Executive Officer, Helio Argos

Beth P. Weinman, JD
Counsel, Ropes & Gray; Former Associate Chief Counsel, FDA

Caroline West, JD
Principal, Loganbrook Advisory LLC; Former SVP Global CCO, Olympus

Amy Wilson, MBA, MSJ
Vice President and Chief Compliance Officer, Esperion Therapeutics

Ronald L. Wisor, Jr, JD
Partner, Hogan Lovells

Olga Zinavenka, CPA, MBA
Senior Director, Compliance Investigations, Endo International

Click Here for Agenda.


The Pharmaceutical Compliance Forum (PCF) is a coalition of compliance professionals including compliance officers and senior legal counsels from 100+ distinguished researched-based pharmaceutical manufacturers and biotech companies.


Joe Zimmerman
Senior Vice President, Chief Compliance Officer, SpringWorks Therapeutics
(PCF Chair)

Christie Camelio
Chief Compliance and Risk Officer, EQRx

Jill Dailey, JD
Vice President & Chief Compliance Officer, Incyte

Joshua M. Marks, JD
Global Head of E&C Program and Governance, Takeda Pharmaceuticals

Margaret Sparks, JD
Head of Compliance, Vaccines & North America Ethics and Business Integrity, Sanofi

Donna White, CCEP
Vice President, Compliance Office, Chiesi


Sujata Dayal, JD
Vice President & Global Chief Compliance Officer, Medline Industries, Inc.

Tara Shewchuk, JD
Chief Ethics & Compliance Officer, Medtronic

Daniel Spicehandler, JD
Vice President Compliance, Commercial Divisions, Stryker





The Congress is pending approval for Compliance Certification Board (CCB)® Continuing Education Units.

The Pharmaceutical and Medical Device Ethics and Compliance Congress has been approved to offer 15.25 Pennsylvania CLE Credits. To qualify for CLE credits, you must (1) pay $100 ands (2) complete and submit the Pharma Congress Continuing Education Credit Self Reporting and Evaluation Form. Click here for details.

Attendees can click here to request a Certificate of Attendance on which they can certify the number of hours they watched and can file with appropriate entities for credit.

The Pharma & Medical Device Congress is now offering a limited number of partial and full Tuition Scholarships to qualifying representatives of government, consumer advocate organizations, academics, students, representatives of health services research organizations, and those who have lost their jobs as a result of the COVID-19 pandemic.

Click here for more information.

For Congress registration information, visit, email, or call 800-503-7419.

For sponsorship and exhibit information contact Suzanne Tyler, Exhibit Manager, at (206) 244-4861 phone, (206) 319-5303 fax, or

For changes or additions, please email your request to:

For removal of your e-mail address, please click the link below for "SafeUnsubscribe" to automatically remove your address from the list.